Clinical Trials

BreastGenitourinaryThoracic

24 enrolled

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Prostatic Neoplasms

NCT07481903 2026-03-19

Effect of Acupuncture on Psychoneurological Symptom Cluster in Breast Cancer Survivors

228 enrolled

Anxiety Disorders, Breast Neoplasms, Depression, Fatigue, Sleep Initiation and Maintenance Disorders, Pain

NCT06148038 2026-03-18

CBD for Breast Cancer Primary Tumors

60 enrolled

Breast Neoplasms

NCT07475923 2026-03-17

Molecular Surveillance In Early Breast Cancer Using The Tumor-Informed ctDNA Assay Myriad Genetics Precise MRD Test; A Prospective Observational Multicenter Study (The MRD Molecular Surveillance Study)

300 enrolled

Breast Neoplasms

NCT07476170 2026-03-17

Real-World Treatment Pattern and Clinical Outcome With Influential Factors of HR+/HER2-aBC 1L Patients in China

14,000 enrolled

Breast Neoplasms

NCT07478315 2026-03-17

IMPOWER-QoL: IMPact Of Discontinuing Premedication for WEekly Paclitaxel on bReast Cancer Patient's Quality Of Life

50 enrolled

Breast Neoplasms, Hypersensitivity

NCT07478705 2026-03-17

EINSTEIN-TNBC

Recurrence, Triple Negative Breast Neoplasms

NCT07478718 2026-03-17

Shoulder Exercise Training on Pain, Range of Motion, and Functional Limitations in Women Following Unilateral Mastectomy

33 enrolled

Breast Neoplasms

NCT07287098 2026-03-16

preEMBER

600 enrolled

Breast Neoplasms

NCT07474090 2026-03-16

STEPS-BC

120 enrolled

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT07475325 2026-03-16

E-C-HAU

500 enrolled

Breast Neoplasms

NCT05874297 2026-03-13

ONE

50 enrolled

Phase 4 Not yet recruiting

Anatomic Stage I Breast Cancer AJCC v8

NCT07257484 2026-03-13

Tirzepatide's Role in Postmenopausal HR+ Breast Cancer Survivors

BreastOther

Breast Neoplasms, Obesity

NCT07470203 2026-03-13

Pyrotinib Combined With Trastuzumab and Pertuzumab for Maintenance Therapy in HER2-Positive Advanced Breast Cancer

42 enrolled

HER2-positive Breast Cancer

NCT07447700 2026-03-12

A Pilot Study to Evaluate the Effectiveness of Focused Massage on Pain, Mobility, and Quality of Life During Radiation Treatment for Patients With Breast Cancer

55 enrolled

Breast Neoplasms

NCT07452055 2026-03-12

EMBRACE

440 enrolled

Primary Breast Cancer

NCT07462351 2026-03-12

SPRING

1,098 enrolled

Breast Neoplasms

NCT07466303 2026-03-12

Serplulimab Combined With Trastuzumab Rezetecan as Neoadjuvant Therapy for Triple-Negative Breast Cancer

84 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT07466927 2026-03-12

Study of Multi-mode Thermal Therapy Combined With Immunotherapy In Patients With HER2-negative Breast Cancer With Liver Metastases

HER2-negative Breast Cancer

NCT07467824 2026-03-12

PREACT

66 enrolled

Breast Neoplasms, Motor Activity

NCT07455955 2026-03-11

Personalized Antiemetic Regimen According to Patients' Pharmacogenetic Profile

200 enrolled

Breast Neoplasms

NCT07464769 2026-03-11

KompXX

358 enrolled

BreastGastrointestinal

Breast Neoplasms, Colorectal Neoplasms

NCT07465172 2026-03-11

GRADE

150 enrolled

Phase 2/3 Not yet recruiting

Breast Neoplasms, Nausea, Vomiting, Weight Loss

NCT07413939 2026-03-10

BREnnA

650 enrolled

Phase EARLY_PHASE1 Not yet recruiting

HER2-positive Breast Cancer

NCT07459283 2026-03-10

The Safety, Dosimetry and Efficacy of 177Lu-INN805 in Patients With Malignant Solid Tumors

10 enrolled

BreastHead & NeckSarcoma

Breast Neoplasms, Head and Neck Neoplasms, Sarcoma, Thyroid Neoplasms

NCT07459738 2026-03-10

A Phase II Study to Evaluate the Efficacy and Safety of HLX43 in Patients With Hormone Receptor Positive, HER2 Negative Locally Advanced or Metastatic Breast Cancer

60 enrolled

Breast Neoplasms

NCT07460752 2026-03-10

Evaluation of Alternative Site Goserelin Acetate Injection for Ovarian Function Suppression (OFS) in Local and Locally Advanced Premenopausal Hormone Receptor Positive Breast Cancer Patients

98 enrolled

Phase 3 Not yet recruiting

Anatomic Stage I Breast Cancer AJCC v8

NCT07461454 2026-03-10

YL202 Versus Treatment of Physician's Choice in Patients With HR+/HER2- Breast Cancer

376 enrolled

Breast Neoplasms

NCT07447414 2026-03-09

LUBRECA

140 enrolled

Breast Neoplasms

NCT07458113 2026-03-09

BERLIN

20 enrolled

BreastCNS

Brain Neoplasms, Triple Negative Breast Neoplasms

NCT07458204 2026-03-09

EPPIL

760 enrolled

Recurrence, Triple Negative Breast Neoplasms

NCT06983691 2026-03-06

Patient Navigation for HER2+ Metastatic Breast Cancer Patients Treated With Tucatinib

26 enrolled

HER2+ Metastatic Breast Cancer (MBC)

NCT07300995 2026-03-06

Behavioral Pain Intervention for Older Cancer Patients

168 enrolled

Breast Neoplasms, Neoplasms, Pain

NCT07454668 2026-03-06

Trastuzumab Deruxtecan + Stereotactic Radiosurgery (SRS) in HER2+ Breast Cancer Brain Metastases

20 enrolled

BreastCNS

Brain Neoplasms, Breast Neoplasms, Neoplasm Metastasis, Neoplasms

NCT07428018 2026-03-05

VIOLET

150 enrolled

Breast Neoplasms

NCT06251544 2026-03-04

TRAIL-R2 and HER2 Bi-Specific Chimeric Antigen Receptor (CAR) T Cells for the Treatment of Metastatic Breast Cancer

27 enrolled

Breast Neoplasms, Mammary Neoplasms, Animal

NCT07449273 2026-03-04

BREATH-RCT

126 enrolled

Anxiety Disorders, Breast Neoplasms, Pain, Postoperative

NCT07276880 2026-03-03

P-RAD(+)TN-DCT

32 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT07446049 2026-03-03

A Single-arm, Open-label, Multicenter, Phase Ib/II Clinical Trial of CVL237 Tablets in Combination With Serplulimab Injection for the Treatment of Advanced Solid Tumors With PTEN Loss or Low Expression

BreastGastrointestinalGynecologicThoracic

180 enrolled

Breast Neoplasms, Uterine Cervical Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Stomach Neoplasms, Endometrial Neoplasms

NCT07446686 2026-03-03

Study on the Safety and Tolerability of Postoperative Radiotherapy Concurrent With CDK4/6 Inhibitors in HR+/HER2- High-Risk Breast Cancer

Phase EARLY_PHASE1 Not yet recruiting

Phase 1/2 Not yet recruiting

Breast Neoplasms

NCT07389733 2026-03-02

A Study of HRS-6208 in Combination With HRS-8080, or Fulvestrant, or Letrozole, With or Without HRS-6209 in Patients With Advanced Unresectable or Metastatic Breast Cancer

180 enrolled

Phase 3 Not yet recruiting

Advanced Unresectable or Metastatic Breast Cancer of Adults

NCT07441460 2026-03-02

A Phase III Study of KN026 in Combination With HB1801 as Adjuvant Therapy for Resectable HER2-Positive Breast Cancer

1,800 enrolled

Resectable HER2-positive Breast Cancer

NCT07441486 2026-03-02

A Single-arm, Prospective, Phase II Clinical Study of the Combination of Entinostat and Oral Paclitaxel in the Treatment of HR+HER2- Advanced Breast Cancer

50 enrolled

Breast Neoplasms

NCT07441512 2026-03-02

A Phase II, Single-arm Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Eribulin in Pretreated Advanced Triple-negative Breast Cancer Harboring a PIK3CA Mutation

26 enrolled

Phase 1/2 Not yet recruiting

Triple Negative Breast Neoplasms

NCT07441889 2026-03-02

HER2 FPBMC in Patients With Metastatic Breast and Prostate Cancer (AM006)

23 enrolled

BreastGenitourinary

Breast Neoplasms, Prostatic Neoplasms

NCT07443774 2026-03-02

AdheRA

81 enrolled

Breast Neoplasms

NCT07443943 2026-03-02

AIMSS-RPS

20 enrolled

Breast Carcinoma In Situ

NCT07109817 2026-02-27

DETOXp

116 enrolled

Breast Neoplasms, Peripheral Nervous System Diseases

NCT07434817 2026-02-27

Trial to Evaluate an Educational Video Series for Women in Breast Cancer Treatment

200 enrolled

Breast Cancer Females

NCT07436312 2026-02-27

U-TRANS